Prestige Consumer Healthcare Inc
PBH
查看详细走势图
62.855USD
+0.435+0.70%
收盘 12/26, 16:00（美东）报价延迟15分钟
3.02B总市值
15.48市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+0.70%
5天
+1.48%
1月
+6.52%
6月
-23.10%
今年开始到现在
-19.51%
1年
-20.18%
查看详细走势图
TradingKey Prestige Consumer Healthcare Inc股票评分
单位: USD 更新时间: 2025-12-24操作建议
Prestige Consumer Healthcare Inc当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在药品行业排名7/158位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价77.50。中期看，股价处于平稳状态。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Prestige Consumer Healthcare Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
6
位分析师
买入
评级
77.500
目标均价
+28.50%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Prestige Consumer Healthcare Inc亮点
亮点风险
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
估值合理
公司最新PE估值15.37，处于3年历史合理位
机构减仓
最新机构持股52.11M股，环比减少3.75%
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓，最新持仓市值190.00
活跃度增加
近期活跃度增加，过去20天平均换手率1.12
Prestige Consumer Healthcare Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Prestige Consumer Healthcare Inc简介
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
公司代码PBH
公司Prestige Consumer Healthcare Inc
CEOLombardi (Ronald M)
网址https://www.prestigebrands.com/
常见问题
Prestige Consumer Healthcare Inc(PBH)的当前股价是多少？
Prestige Consumer Healthcare Inc(PBH)的当前股价是 62.855。
Prestige Consumer Healthcare Inc的股票代码是什么？
Prestige Consumer Healthcare Inc的股票代码是PBH。
Prestige Consumer Healthcare Inc股票的52周最高点是多少？
Prestige Consumer Healthcare Inc股票的52周最高点是90.040。
Prestige Consumer Healthcare Inc股票的52周最低点是多少？
Prestige Consumer Healthcare Inc股票的52周最低点是57.250。
Prestige Consumer Healthcare Inc的市值是多少？
Prestige Consumer Healthcare Inc的市值是3.02B。
Prestige Consumer Healthcare Inc的净利润是多少？
Prestige Consumer Healthcare Inc的净利润为214.60M。
现在Prestige Consumer Healthcare Inc(PBH)的股票是买入、持有还是卖出？
根据分析师评级，Prestige Consumer Healthcare Inc(PBH)的总体评级为买入，目标价格为77.500。
Prestige Consumer Healthcare Inc(PBH)股票的每股收益（EPS TTM）是多少
Prestige Consumer Healthcare Inc(PBH)股票的每股收益（EPS TTM）是4.061。
相关品种
